Highlander Capital Management’s Avanos Medical AVNS Stock Holding History

Highlander Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-337	Closed	-$23K	–	696
2018 Q3	$23K	Hold	337	–	–	0.01%	472
2018 Q2	$19K	Hold	337	–	–	0.01%	514
2018 Q1	$16K	Hold	337	–	–	0.01%	526
2017 Q4	$16K	Hold	337	–	–	0.01%	526
2017 Q3	$15K	Hold	337	–	–	0.01%	548
2017 Q2	$13K	Hold	337	–	–	0.01%	569
2017 Q1	$13K	Hold	337	–	–	0.01%	570
2016 Q4	$12K	Hold	337	–	–	0.01%	577
2016 Q3	$12K	Hold	337	–	–	0.01%	591
2016 Q2	$11K	Hold	337	–	–	0.01%	606
2016 Q1	$10K	Hold	337	–	–	0.01%	616
2015 Q4	$11K	Hold	337	–	–	0.01%	623
2015 Q3	$9K	Hold	337	–	–	0.01%	677
2015 Q2	$14K	Hold	337	–	–	0.01%	602
2015 Q1	$17K	Buy	337 +300	+811%	+$13.9K	0.01%	578
2014 Q4	$2K	Buy	+37	New	+$1.45K	﹤0.01%	800

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Highlander Capital Management's AVNS Position: Q4 2018 in Review

Highlander Capital Management sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 337 shares — an estimated $23K sold.

Highlander Capital Management first reported a position in AVNS in Q4 2014 and held it in 16 quarters. The position peaked at $23K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

Highlander Capital Management reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
Highlander Capital Management sold 337 Avanos Medical shares in Q4 2018, an estimated $23K.
Highlander Capital Management first reported a position in Avanos Medical in Q4 2014 and held it in 16 quarters.
Highlander Capital Management's Avanos Medical position peaked at $23K in Q3 2018.
350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Highlander Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.